Literature DB >> 30322600

What to Look for on Post-stroke Neuroimaging.

Angelos M Katramados1, Lotfi Hacein-Bey2, Panayiotis N Varelas3.   

Abstract

The most feared complication after acute ischemic stroke is symptomatic or asymptomatic hemorrhagic conversion. Neuroimaging and clinical criteria are used to predict development of hemorrhage. Seizures after acute ischemic stroke or stroke-like symptoms from seizures are not common but may lead to confusion in the peristroke period, especially if seizures are repetitive or evolve into status epilepticus, which could affect neuroimaging findings. Malignant infarction develops when cytotoxic edema is large enough to lead to herniation and death. Post-stroke neuroimaging prognosticators have been described and should be assessed early so that appropriate treatment is offered before herniation leads to additional tissue injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Hemorrhagic transformation; Neuroimaging; Seizure

Mesh:

Year:  2018        PMID: 30322600     DOI: 10.1016/j.nic.2018.06.007

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  2 in total

1.  Unsupervised Deep Learning for Stroke Lesion Segmentation on Follow-up CT Based on Generative Adversarial Networks.

Authors:  H van Voorst; P R Konduri; L M van Poppel; W van der Steen; P M van der Sluijs; E M H Slot; B J Emmer; W H van Zwam; Y B W E M Roos; C B L M Majoie; G Zaharchuk; M W A Caan; H A Marquering
Journal:  AJNR Am J Neuroradiol       Date:  2022-07-28       Impact factor: 4.966

2.  Brain Magnetic Resonance Imaging Volumetric Measures of Functional Outcome after Severe Traumatic Brain Injury in Adolescents.

Authors:  Peter Ferrazzano; Benjamin Yeske; Jeanette Mumford; Gregory Kirk; Erin D Bigler; Katherine Bowen; Nicole O'Brien; Bedda Rosario; Sue R Beers; Paul Rathouz; Michael J Bell; Andrew L Alexander
Journal:  J Neurotrauma       Date:  2021-02-24       Impact factor: 4.869

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.